Services
Investment Banking
Equity Research
Capital Markets
Wealth Management
About
Leadership
Locations
Our History
Transactions
Resources
Press Releases
Company News
Login
Wealthscape
Research Portal
Transaction Information Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet") announced... Read More
Ladenburg Thalmann served as Lead Bookrunner for this offering. Since 2017, Ladenburg has led 60 fixed income... Read More
Transaction Information Calidi Biotherapeutics, Inc. (NYSE American: CLDI or "Calidi") announced the closing of its... Read More
Ladenburg also acts as Exclusive Advisor for In-License of Phase 3 Ready Asset, eRapa for Familial Adenomatous... Read More
Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company") announced the... Read More
Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) announced that it has closed its private placement with... Read More
Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company") announced an... Read More
Transaction Information Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company") announced the closing of its... Read More
Transaction Information Immunic, Inc. (Nasdaq: IMUX) announced it has entered into a securities purchase agreement... Read More